Goldman Sachs’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,292
Closed -$47.7K 6751
2025
Q3
$47.7K Buy
+14,292
New +$49.5K ﹤0.01% 6176

Other funds holding PYPD

Goldman Sachs's PYPD Position: Q4 2025 in Review

Goldman Sachs sold out of PolyPid (PYPD) in Q4 2025, closing a stake of 14,292 shares — an estimated $47.7K sold.

Goldman Sachs first reported a position in PYPD in Q3 2025 and held it in 1 quarter. The position peaked at $47.7K in Q3 2025. 19 funds tracked by Wall St. Rank hold PYPD as of Q4 2025.

  • Goldman Sachs reported no remaining PolyPid position as of Q4 2025 after selling out during the quarter.
  • Goldman Sachs sold 14,292 PolyPid shares in Q4 2025, an estimated $47.7K.
  • Goldman Sachs first reported a position in PolyPid in Q3 2025 and held it in 1 quarter.
  • Goldman Sachs's PolyPid position peaked at $47.7K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held PolyPid as of Q4 2025.

Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.